Post-earnings recap
Reported
Tue, Apr 30, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
38%
This earnings report indicates that Twist Bioscience is facing challenges, as evidenced by the significant drop in stock price following the announcement. The lack of revenue figures and guidance may have contributed to investor uncertainty, leading to the 14.71% decline in stock value. Investors will be looking for more clarity in future communications from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.93 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management's tone was defensive, highlighting ongoing challenges without providing specific guidance. They emphasized the need to navigate current market conditions carefully.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The company acknowledged challenges in the current market environment.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—